Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients.
Sticky platelet syndrome (SPS) leads to hyperaggregabilty of platelets in response to physiologic stimuli. In this report we describe three patients with clinical symptoms of SPS after renal transplantation. The first patient developed an infarction of her transplant kidney with additional, subsequent renal microinfarctions. The second patient suffered multiple strokes and deep vein thrombosis with episodes of pulmonary embolism and ischemic bowel disease due to colonic microinfarctions. The third patient experienced a long episode of unexplained respiratory and graft dysfunction immediately after transplantation until therapy for SPS was initiated, at which point symptoms resolved quickly. Kidney transplant recipients with SPS may be at increased risk of developing thrombosis, given that most immunosuppressive drugs are known to induce either endothelial cell damage or augment platelet aggregation. All patients awaiting renal transplantation should be screened for a history of thrombosis and, if appropriate, tested for SPS. Affected patients should receive dose-adjusted acetylsalicylic acid.
Mühlfeld
A S
AS
Division of Nephrology and Immunology, University of Aachen, Aachen, Germany.
Ketteler
M
M
Schwamborn
K
K
Eitner
F
F
Schneider
B
B
Gladziwa
U
U
Knüchel
R
R
Floege
J
J
D000293:Adolescent; D001791:Blood Platelet Disorders / Q000175:diagnosis*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D010974:Platelet Aggregation; D011183:Postoperative Complications / Q000175:diagnosis*; D013923:Thromboembolism / Q000175:diagnosis*